Idorsia's development compounds target a number of different diseases.

Fabry disease

Fabry disease

Fabry disease is a rare inherited disorder in which a particular lipid (a fat-like substance) can’t be broken down by the body, leading to its build-up in the cells of the body organs.

Insomnia

Insomnia

Insomnia is defined as a combination of both dissatisfaction with sleep and a significant negative impact on daytime functioning. Insomnia is, worldwide, the most commonly reported sleeping disorder.

Resistant Hypertension Management

Resistant Hypertension Management

Resistant hypertension is associated with a higher risk of cardiovascular disease. In addition, patients with resistant hypertension often have a medical history of diabetes mellitus and may develop chronic kidney disease as a complication of the hypertension, increasing their vulnerability and the complexity of treatment.

Cerebral vasospasm associated with aSAH

Cerebral vasospasm associated with aSAH

Aneurysmal subarachnoid hemorrhage (aSAH) is a sudden life-threatening bleeding occurring in the subarachnoid space. In about one third of aSAH patients, a worsening of their condition may occur due to delayed cerebral vasospasm.

Systemic lupus erythematosus

Systemic lupus erythematosus

Systemic lupus erythematosus (SLE), the most common form of Lupus, is an autoimmune disease which can affect the skin, joints, kidneys, brain and other organs.